Balyasny Asset Management
MESO

Balyasny Asset Management’s Mesoblast MESO Stock Holding History

Balyasny Asset Management’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-29,860
Closed -$152K – 3047
2022
Q3 		$152K Buy
+29,860
New +$180K ﹤0.01% 2354

Other funds holding MESO

MGIM
M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Balyasny Asset Management's MESO Position: Q4 2022 in Review

Balyasny Asset Management sold out of Mesoblast (MESO) in Q4 2022, closing a stake of 29,860 shares — an estimated $152K sold.

Balyasny Asset Management first reported a position in MESO in Q3 2022 and held it in 1 quarter. The position peaked at $152K in Q3 2022. 42 funds tracked by Wall St. Rank hold MESO as of Q4 2022.

  • Balyasny Asset Management reported no remaining Mesoblast position as of Q4 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 29,860 Mesoblast shares in Q4 2022, an estimated $152K.
  • Balyasny Asset Management first reported a position in Mesoblast in Q3 2022 and held it in 1 quarter.
  • Balyasny Asset Management's Mesoblast position peaked at $152K in Q3 2022.
  • 42 funds tracked by Wall St. Rank held Mesoblast as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.